We are live on
!
Find out more
SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$2.67B
1-Year Est. Return
21.74%
This Fund
S&P 500
This Quarter
Est. Return
+6.56%
1 Year Est. Return
+21.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$2.04B
(+2,069%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
90.57%
Top 10 Holdings %
Top 10 Hldgs %
16.01%
Holding
701
New
636
Increased
22
Reduced
4
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$43.5M |
| 2 |
Pfizer
PFE
|
+$40.7M |
| 3 |
CVS Health
CVS
|
+$39.7M |
| 4 |
Philip Morris
PM
|
+$38.1M |
| 5 |
JPMorgan Chase
JPM
|
+$32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$20.3M |
| 2 |
Workday
WDAY
|
+$8.99M |
| 3 |
Ferguson
FERG
|
+$8.32M |
| 4 |
ANSS
Ansys
ANSS
|
+$5.21M |
| 5 |
Mercado Libre
MELI
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.3% |
| 2 | Industrials | 14.85% |
| 3 | Financials | 12.55% |
| 4 | Utilities | 10.01% |
| 5 | Consumer Staples | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
NewMarket
NEU
$8.59B
| $233K | 0.01% |
+367
| New | +$220K |
|
602
Ryan Specialty Holdings
RYAN
$11B
| $228K | 0.01% |
+4,100
| New | +$196K |
|
603
Cadre Holdings
CDRE
$1.44B
| $225K | 0.01% |
+6,223
| New | +$217K |
|
604
The RealReal
REAL
$1.36B
| $225K | 0.01% |
+57,592
| New | +$137K |
|
|
BFS
605
Saul Centers
BFS
$850M
| $224K | 0.01% |
+5,824
| New | +$221K |
|
|
HUYA
606
Huya Inc
HUYA
$547M
| $222K | 0.01% |
+48,771
| New | +$176K |
|
607
Kelly Services Class A
KELYA
$536M
| $221K | 0.01% |
+8,820
| New | +$198K |
|
608
Phillips Edison & Co
PECO
$5.17B
| $219K | 0.01% |
+6,100
| New | +$216K |
|
609
Rayonier Advanced Materials
RYAM
$561M
| $219K | 0.01% |
+45,751
| New | +$195K |
|
|
ODP
610
DELISTED
ODP
ODP
| $218K | 0.01% |
+4,100
| New | +$214K |
|
611
Erasca
ERAS
$6.45B
| $216K | 0.01% |
+104,691
| New | +$209K |
|
|
LAZR
612
DELISTED
Luminar Technologies
LAZR
| $214K | 0.01% |
+7,227
| New | +$264K |
|
613
Fulgent Genetics
FLGT
$515M
| $213K | 0.01% |
+9,816
| New | +$244K |
|
614
Shenandoah Telecom
SHEN
$721M
| $211K | 0.01% |
+12,163
| New | +$236K |
|
615
Grindr
GRND
$2.76B
| $209K | 0.01% |
+20,625
| New | +$184K |
|
616
Organogenesis Holdings
ORGO
$233M
| $207K | 0.01% |
+72,929
| New | +$248K |
|
617
National Healthcare
NHC
$3.47B
| $206K | 0.01% |
+2,177
| New | +$206K |
|
618
QCR Holdings
QCRH
$1.73B
| $205K | 0.01% |
+3,380
| New | +$193K |
|
619
Summit Therapeutics
SMMT
$12B
| $202K | 0.01% |
48,877
-37,335
| -43% | -$148K |
|
|
MRC
620
DELISTED
MRC Global
MRC
| $201K | 0.01% |
+16,000
| New | +$181K |
|
|
FINV
621
FinVolution Group
FINV
$1.07B
| $196K | 0.01% |
38,884
| – | – |
|
622
Aemetis
AMTX
$126M
| $195K | 0.01% |
32,542
-6,938
| -18% | -$26.3K |
|
623
Taboola.com
TBLA
$1.05B
| $195K | 0.01% |
+43,897
| New | +$196K |
|
|
KALV
624
DELISTED
KalVista Pharmaceuticals
KALV
| $192K | 0.01% |
+16,179
| New | +$216K |
|
625
Lyell Immunopharma
LYEL
$347M
| $191K | 0.01% |
+4,288
| New | +$184K |
|
Similar funds
TCAM
VA
MMEA
PCIG
MG
CCM
ACM
LP
Susquehanna Fundamental Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Susquehanna Fundamental Investments held 701 positions worth $2.14B, up 2,069% from $98.8M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Susquehanna Fundamental Investments deployed $1.94B of net new capital in Q1 2024, opening 636 new positions and adding to 22 existing holdings. Its largest new stake was Boeing: 211,714 shares worth $40.9M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Summit Therapeutics, an estimated $148K trimmed.
- Susquehanna Fundamental Investments's largest Q1 2024 buy was Boeing: 211,714 shares worth $40.9M.
- Susquehanna Fundamental Investments added most to Verisk Analytics in Q1 2024, an estimated $19.8M increase.
- Susquehanna Fundamental Investments's biggest Q1 2024 reduction was Summit Therapeutics, cutting an estimated $148K.
- Susquehanna Fundamental Investments fully exited Uber in Q1 2024, selling an estimated $20.3M.
- Susquehanna Fundamental Investments's ten largest holdings make up 16% of its $2.14B portfolio in Q1 2024.
- Susquehanna Fundamental Investments opened 636 new positions and closed 36 in Q1 2024.
- Susquehanna Fundamental Investments's portfolio value rose 2,069% quarter-over-quarter to $2.14B.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2024, filed 7 May 2024.